Page last updated: 2024-11-06

lysergic acid diethylamide and Cardiovascular Diseases

lysergic acid diethylamide has been researched along with Cardiovascular Diseases in 2 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raval, MV1
Gaba, RC1
Brown, K1
Sato, KT1
Eskandari, MK1
Ghuran, A1
Nolan, J1

Reviews

1 review available for lysergic acid diethylamide and Cardiovascular Diseases

ArticleYear
Recreational drug misuse: issues for the cardiologist.
    Heart (British Cardiac Society), 2000, Volume: 83, Issue:6

    Topics: Adolescent; Adult; Amphetamines; Cannabis; Cardiovascular Diseases; Child; Cocaine; Drug Overdose; F

2000

Other Studies

1 other study available for lysergic acid diethylamide and Cardiovascular Diseases

ArticleYear
Percutaneous transluminal angioplasty in the treatment of extensive LSD-induced lower extremity vasospasm refractory to pharmacologic therapy.
    Journal of vascular and interventional radiology : JVIR, 2008, Volume: 19, Issue:8

    Topics: Adult; Angioplasty, Balloon; Cardiovascular Diseases; Female; Humans; Leg; Lysergic Acid Diethylamid

2008